Kaiser Permanente

Kaiser Permanente is a nonprofit healthcare organization that offers a variety of services, including preventive care, emergency care, hospital services, and pharmacy offerings. Founded in 1945 and headquartered in Oakland, California, it serves members across multiple states, including California, Colorado, Georgia, Hawaii, Ohio, Oregon, Washington, and the District of Columbia. The organization is recognized as a leader in the healthcare sector, focusing on comprehensive care that encompasses well-baby and prenatal services, immunizations, and diagnostic screenings. Additionally, Kaiser Permanente Ventures, its venture capital arm established in 1997, invests in innovative healthcare companies in the United States, targeting sectors such as medical devices, therapeutics, health care services, and health care information technology. The venture arm typically invests between $0.5 million and $12 million in companies with significant market potential and prefers to collaborate with other investors in the healthcare space.

Amy Belt

Managing Director

Samuel E. Brasch

Senior VP & Senior MD

Olivia Capra

Senior Associate

Christopher M. Grant

Chief Operating Officer & Executive Vice President

Nemariam Mesfin

Director of Finance

Liz Rockett

MD

Chris Stenzel

SVP, Business Development and Innovation

126 past transactions

Kate Farms

Series C in 2022
Kate Farms, Inc. specializes in producing vegan meal replacement shakes and plant-based tube feeding solutions. Founded in 2011 and headquartered in Santa Barbara, California, with an additional office in Waltham, Massachusetts, the company has established itself as a leader in the market for plant-based enteral formulas. Its products are designed to be nutritionally advanced and well-tolerated by patients, being free of common allergens such as soy, dairy, and corn. Clinicians have reported that patients using Kate Farms products experience reduced gastrointestinal intolerance, improved weight and growth, and enhanced overall nutritional status. By combining science and natural ingredients, Kate Farms aims to significantly improve health outcomes for individuals with varying medical and dietary needs, providing a nourishing alternative that prioritizes both well-being and choice in nutritional care. The company's products are available through a network of retail stores across the United States and online.

Incredible Health

Series B in 2022
Incredible Health, Inc. is a San Francisco-based company that offers an online recruitment platform designed to assist healthcare providers in hiring full-time clinical staff efficiently. The platform enables hospitals and health systems to find high-quality clinicians in less than 30 days, streamlining the staffing process. Unlike traditional job searches, candidates do not apply to employers; instead, employers seek out candidates through an intuitive web application. Incredible Health also provides a mobile application that enhances the user experience. The company, originally known as Lift League, Inc., was incorporated in 2015 and has since focused on solving staffing challenges within the healthcare industry by allowing users to filter job searches, receive alerts, and access career advice.

Everytable

Series C in 2022
Everytable, PBC, doing business as Everytable, owns and operates grab-and-go restaurants. It offers food and meals, including chicken caesar and cobb salads, Puebla chicken tinga, Jamaican jerk chicken, Cajun blackened fish food, pozole rojo, Yucatan chili, and more; and kids meals, such as spaghetti and meatballs, and picnic party boxes. Everytable, PBC was formerly known as Harvest Fresh Foods, PBC and changed its name to Everytable, PBC in November 2017. The company was founded in 2015 and is based in Los Angeles, California.

Ordr

Series C in 2022
Ordr is a technology company that specializes in Internet of Things (IoT) security solutions designed for hyper-connected enterprises. Founded in 2015 and based in Santa Clara, California, Ordr develops an AI-based systems control engine that maps the device flow genome at scale. The company's platform employs machine learning to continuously inspect, classify, and establish baseline behaviors for each device within an organization. This unique software architecture enables real-time processing of large data volumes, allowing for closed-loop security. By generating tailored security policies for various device classes, Ordr integrates these measures with existing multi-vendor network and security infrastructures, helping organizations effectively manage and protect their business-critical devices and systems.

Tidelift

Series C in 2022
Tidelift makes open source work better—for everyone. Through the Tidelift Subscription and in direct partnership with maintainers, Tidelift is a single source for proactively managed open source components and professional assurances around those components. Tidelift makes it possible for open source projects to thrive, so we can all create even more incredible software, even faster.

Zepto

Series D in 2022
Zepto offers a 10-minute grocery delivery service.

IntelyCare

Series C in 2022
IntelyCare offers a digital workforce augmentation platform that combines a gig-model application with advanced data science to optimize staff resources and close the widening gap between workforce supply and demand. IntelyCare is revolutionizing the antiquated healthcare staffing market, filling nursing shifts at three times the industry average and giving post-acute facilities the tools to predict and manage staffing needs. The company’s engaging mobile app empowers nursing professionals with access to flexible, on-demand work opportunities, reducing burnout and attrition while increasing productivity.

Osso VR

Series C in 2022
Osso VR Inc. is a company that develops a virtual reality surgical training platform aimed at enhancing the skills of surgeons, sales teams, and medical trainees across various specialties, particularly orthopedics. Founded in 2016 and based in Palo Alto, California, the company provides an immersive training environment that simulates surgical processes with realistic, haptic-enhanced interactions. This platform facilitates both novice and experienced medical professionals in mastering the latest surgical techniques and instruments through hands-on experiences. Additionally, Osso VR offers analytic dashboards and personalized guidance to further support the learning process, making it a valuable resource in the field of medical education and training.

AnyRoad

Series B in 2022
AnyRoad Inc. operates a platform that connects tourism customers with professional tour guides, allowing users to find, book, and experience tours in various global locations, including Rio de Janeiro, San Francisco, New York, London, Tokyo, and Israel. Founded in 2012 and based in San Francisco, the company also provides an experience relationship management (ERM) platform designed to help brands measure, scale, and implement their experiential marketing campaigns. This software integrates with customer relationship management, loyalty, enterprise resource planning, and point-of-sale systems, enabling companies to develop brand loyalty, influence consumer behavior, and gain insights into brand associations. AnyRoad's clients include well-known brands such as Budweiser, Honda, Michaels, and Tabasco.

Secureframe

Series B in 2022
Secureframe is a compliance automation platform designed to assist organizations in achieving and maintaining compliance with security and privacy standards, specifically SOC 2 and ISO 27001. Founded in 2020 by Shrav Mehta and Natasja Nielsen, the company is headquartered in San Francisco, California. Secureframe's software streamlines the compliance process by offering automated audits and continuous monitoring, ensuring that service providers effectively manage data to protect both organizational interests and client privacy. This platform enables companies worldwide to navigate the complexities of compliance, thereby enhancing their security posture and maintaining adherence to critical global standards.

Big Health

Series C in 2022
Big Health is a London-based company that develops and markets digital healthcare solutions focused on improving mental health and sleep disorders. Its flagship product, Sleepio, is a digital sleep improvement program that utilizes Cognitive Behavioral Therapy techniques to address individual sleep challenges. The platform offers fully-automated, personalized therapeutic sessions, allowing users to engage with their specific issues and track their progress. In addition to Sleepio, Big Health provides a broader digital healthcare portal that delivers customized behavioral programs aimed at various mental health concerns, all designed in consultation with medical professionals to ensure efficacy and relevance.

DexCare

Series B in 2022
DexCare is a provider of Platform-as-a-Service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform into a highly scalable digital experience for their patients— increasing revenue from new, digital-first patients while minimizing new patient acquisition costs. DexCare was founded in 2021 and is headquartered in Seattle, WA.

Medically Home

Venture Round in 2022
Medically Home Group, Inc., based in Boston, Massachusetts, offers a virtual hospital program designed to deliver in-home medical care services. Founded in 2016, the company focuses on providing patient-centered care for individuals with serious or complex illnesses, including conditions such as heart failure, pneumonia, urinary tract infections, cellulitis, and respiratory issues. Medically Home's innovative model enables the safe transition of medical care from traditional hospital settings to patients' homes, allowing for centralized, on-demand management of acute medical needs. This approach connects patients with caregivers while facilitating monitoring and communication, ensuring that patients and their families receive comprehensive support in a familiar environment.

NOCD

Series B in 2021
NOCD Inc. develops and operates a mobile application that connects mental health practitioners and people with obsessive compulsive disorder (OCD). Its application uses cognitive behavioral therapy techniques to assist in treating OCD patients. The company also helps OCD patients to find clinically supported treatment; and operates an online platform for OCD treatment. NOCD Inc. was founded in 2014 and is based in Chicago, Illinois.

Genome Medical

Series C in 2021
Genome Medical, Inc. is a national telegenomics company that specializes in providing genetic consultation and medical consulting services. Incorporated in 2016 and based in South San Francisco, California, the company utilizes its Genome Care Delivery technology platform to deliver genetic solutions across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By leveraging a nationwide network of genetic specialists, Genome Medical offers expert virtual genetic care to individuals and families, enhancing their health and well-being. The company also assists healthcare providers and patients in navigating the expanding field of genetics, enabling them to interpret test results, assess disease risk, expedite diagnoses, make informed treatment choices, and reduce healthcare costs.

Abogen Biosciences

Series C in 2021
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based (RNA and DNA) therapeutics for treatment of cancer and infectious diseases.

OM1

Series D in 2021
OM1 (formerly Better Outcomes) is a digital health company focused on solving the problem of determining and understanding the true results of healthcare. We believe that a value-based healthcare system requires a much more complete view of patient outcomes than has been available until now. We leverage a state-of-the-art technology platform, a world-class team of scientists, clinical experts and software engineers, and a committed network of organizations to create a new standard for health outcomes information.

Spinny

Series D in 2021
Spinny is a technology-driven platform that simplifies the buying and selling of used cars in India. Founded in 2015 and headquartered in Gurgaon, Haryana, Spinny aims to create a trustworthy and hassle-free experience for customers in the pre-owned car market. The company employs a full-stack business model, ensuring transparency and value in every transaction. Spinny offers a selection of handpicked cars, complete with detailed information, and provides potential buyers with the opportunity for a test drive and a five-day money-back guarantee. This approach enables car owners to list their vehicles easily while offering buyers a straightforward and reliable process for purchasing their desired cars.

Osso VR

Series B in 2021
Osso VR Inc. is a company that develops a virtual reality surgical training platform aimed at enhancing the skills of surgeons, sales teams, and medical trainees across various specialties, particularly orthopedics. Founded in 2016 and based in Palo Alto, California, the company provides an immersive training environment that simulates surgical processes with realistic, haptic-enhanced interactions. This platform facilitates both novice and experienced medical professionals in mastering the latest surgical techniques and instruments through hands-on experiences. Additionally, Osso VR offers analytic dashboards and personalized guidance to further support the learning process, making it a valuable resource in the field of medical education and training.

Protenus

Series D in 2021
The Protenus healthcare compliance analytics platform uses artificial intelligence to audit every access to patient records for the nation’s leading health systems. Providing healthcare leaders full insight into how health data is being used, and alerting compliance teams to policy violations, Protenus helps our partner hospitals make decisions about how to better protect their data, their patients, and their institutions. Learn more at Protenus.com and follow us on Twitter @Protenus.

PathAI

Series C in 2021
PathAI, Inc. develops artificial intelligence-based technology solutions for pathology laboratories. It develops a technology that assists pathologists in making rapid and accurate diagnoses for patients. The company also builds solutions to help identify patients that benefit from novel therapies, to make scalable personalized medicine a reality. PathAI, Inc. was founded in 2016 and is based in Boston, Massachusetts with an additional office in Austin, Texas.

Medically Home

Corporate Round in 2021
Medically Home Group, Inc., based in Boston, Massachusetts, offers a virtual hospital program designed to deliver in-home medical care services. Founded in 2016, the company focuses on providing patient-centered care for individuals with serious or complex illnesses, including conditions such as heart failure, pneumonia, urinary tract infections, cellulitis, and respiratory issues. Medically Home's innovative model enables the safe transition of medical care from traditional hospital settings to patients' homes, allowing for centralized, on-demand management of acute medical needs. This approach connects patients with caregivers while facilitating monitoring and communication, ensuring that patients and their families receive comprehensive support in a familiar environment.

Groups Recover Together

Series C in 2021
Groups Recover Together was founded to make treatment for opioid addiction respectful, accessible, and affordable. We empower our members to regain control of their lives through a proven, evidence-based model of medication-assisted treatment (MAT) with buprenorphine and weekly group therapy.

Vesta Healthcare

Venture Round in 2021
Vesta Healthcare is an industry-leading technology and clinical services organization, dedicated to connecting caregiver insights to the rest of the care team. Vesta Healthcare proactively identifies the need for additional resources in the home and provides 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to create value-based population health programs that emphasize clinical quality, improved health outcomes and personalized engagement. Vesta Healthcare is headquartered in New York, NY.

Evidation Health

Series E in 2021
Evidation Health is a provider of a health data analytics platform designed to collect and analyze continuous behavior data and healthcare information so as to create better health outcomes. Its platform turns raw, high-frequency everyday behavior data from sensors, devices, speech, video, and other sources into new knowledge about health and disease, that enable individuals and innovative companies to understand and influence the everyday behaviors. It was founded in 2012 and is headquartered in San Mateo, California.

DexCare

Series A in 2021
DexCare is a provider of Platform-as-a-Service offering to manage health system capacity and demand across all lines of care. The company enables health systems to evolve their traditional, one-to-one, patient-to-provider relationships and transform into a highly scalable digital experience for their patients— increasing revenue from new, digital-first patients while minimizing new patient acquisition costs. DexCare was founded in 2021 and is headquartered in Seattle, WA.

Nuvolo

Series C in 2021
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform built on the ServiceNow framework. Established in 2013 and headquartered in Paramus, New Jersey, with additional offices in London, Bulgaria, and India, Nuvolo specializes in life-cycle management solutions for assets in clinics, laboratories, facilities, and manufacturing sectors. The company provides a comprehensive suite of services that includes implementation, support, tracking, reporting, and analytics, aimed at enhancing the user experience for mobile and remote workforces. Known for its commitment to innovation and customer service, Nuvolo has formed strategic partnerships with major firms such as Atos, KPMG, and Unisys to further its mission of becoming a leader in cloud-based enterprise asset management.

K Health

Series E in 2021
K Health, Inc. develops and provides a health application that provides personalized and data-driven information about their symptoms and health. The company was formerly known as Kang Health, Inc. and changed its name to K Health, Inc. in November 2018. K Health, Inc. was incorporated in 2016 and is based in New York, New York with an additional office in Israel.

dMed

Series C in 2020
dMed Company Limited, also known as, dMed Biopharmaceutical Co., Ltd. operates as clinical contract research organization providing services for development of medicines and medical devices. The company offer services, including consulting, clinical operations, biostatistics & programming, data management, pharmacovigilance, clinical science & medical affairs, quality assurance, and regulatory affairs & Strategy. It serves biopharmaceutical and medical device companies. dMed Company Limited was founded in 2016 and is based in Shanghai, China.

Everytable

Series B in 2020
Everytable, PBC, doing business as Everytable, owns and operates grab-and-go restaurants. It offers food and meals, including chicken caesar and cobb salads, Puebla chicken tinga, Jamaican jerk chicken, Cajun blackened fish food, pozole rojo, Yucatan chili, and more; and kids meals, such as spaghetti and meatballs, and picnic party boxes. Everytable, PBC was formerly known as Harvest Fresh Foods, PBC and changed its name to Everytable, PBC in November 2017. The company was founded in 2015 and is based in Los Angeles, California.

Kate Farms

Series B in 2020
Kate Farms, Inc. specializes in producing vegan meal replacement shakes and plant-based tube feeding solutions. Founded in 2011 and headquartered in Santa Barbara, California, with an additional office in Waltham, Massachusetts, the company has established itself as a leader in the market for plant-based enteral formulas. Its products are designed to be nutritionally advanced and well-tolerated by patients, being free of common allergens such as soy, dairy, and corn. Clinicians have reported that patients using Kate Farms products experience reduced gastrointestinal intolerance, improved weight and growth, and enhanced overall nutritional status. By combining science and natural ingredients, Kate Farms aims to significantly improve health outcomes for individuals with varying medical and dietary needs, providing a nourishing alternative that prioritizes both well-being and choice in nutritional care. The company's products are available through a network of retail stores across the United States and online.

Osso VR

Series A in 2020
Osso VR Inc. is a company that develops a virtual reality surgical training platform aimed at enhancing the skills of surgeons, sales teams, and medical trainees across various specialties, particularly orthopedics. Founded in 2016 and based in Palo Alto, California, the company provides an immersive training environment that simulates surgical processes with realistic, haptic-enhanced interactions. This platform facilitates both novice and experienced medical professionals in mastering the latest surgical techniques and instruments through hands-on experiences. Additionally, Osso VR offers analytic dashboards and personalized guidance to further support the learning process, making it a valuable resource in the field of medical education and training.

Truepill

Series C in 2020
Truepill is a B2B pharmacy fulfillment service. They provide a pharmacy API and fulfillment of medications to 50 states from their own facilities. They work directly with D2C consumer brands (e.g. Hims, Nurx), digital health companies, and other healthcare organizations. They are a team of 150 employees and have raised funding from Initialized Capital, Y Combinator, Slow Ventures, Sound Ventures, Tuesday Capital, Foundation Capital, Index Ventures, Social Capital, Box Group, Joe Montana, and others. Founded in 2016 by Umar Afridi and Sid Viswanathan, Truepill is headquartered in San Mateo, California.

Ginger

Series D in 2020
Ginger.io, Inc. operates a behavioral analytics platform that transforms mobile data into health insights, specifically focusing on mental healthcare. The platform provides users with instant access to evidence-based behavioral health coaching, therapy, and psychiatry through a smartphone application. This on-demand service connects behavioral health coaches, therapists, and psychiatrists to deliver personalized care around the clock. Users can collect and analyze both passive mobile sensor data and active patient-reported outcomes, allowing for the identification of behavioral patterns and novel findings. Ginger serves a diverse clientele, including researchers, physicians, healthcare providers, and millions of individuals through partnerships with leading employers and health plans. Founded in 2010 and headquartered in San Francisco, California, Ginger is dedicated to enhancing mental health support.

Genome Medical

Series B in 2020
Genome Medical, Inc. is a national telegenomics company that specializes in providing genetic consultation and medical consulting services. Incorporated in 2016 and based in South San Francisco, California, the company utilizes its Genome Care Delivery technology platform to deliver genetic solutions across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By leveraging a nationwide network of genetic specialists, Genome Medical offers expert virtual genetic care to individuals and families, enhancing their health and well-being. The company also assists healthcare providers and patients in navigating the expanding field of genetics, enabling them to interpret test results, assess disease risk, expedite diagnoses, make informed treatment choices, and reduce healthcare costs.

Cedar

Series C in 2020
Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevate the end-to-end patient experience. The platform leverages advanced data science to customize and simplify the payment experience, resulting in a modern, consumer-friendly way for patients to plan for and pay their bills. It was founded in 2016 and is headquartered in New York, New York.

Big Health

Series B in 2020
Big Health is a London-based company that develops and markets digital healthcare solutions focused on improving mental health and sleep disorders. Its flagship product, Sleepio, is a digital sleep improvement program that utilizes Cognitive Behavioral Therapy techniques to address individual sleep challenges. The platform offers fully-automated, personalized therapeutic sessions, allowing users to engage with their specific issues and track their progress. In addition to Sleepio, Big Health provides a broader digital healthcare portal that delivers customized behavioral programs aimed at various mental health concerns, all designed in consultation with medical professionals to ensure efficacy and relevance.

Orca Bio

Series D in 2020
Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to these patients. Orca Bio has developed a pipeline of proprietary technologies that have the potential to impact over 100 malignant and auto-immune diseases. Orca has assembled a team of world-leading experts and technologists to execute this vision.

Ordr

Series B in 2020
Ordr is a technology company that specializes in Internet of Things (IoT) security solutions designed for hyper-connected enterprises. Founded in 2015 and based in Santa Clara, California, Ordr develops an AI-based systems control engine that maps the device flow genome at scale. The company's platform employs machine learning to continuously inspect, classify, and establish baseline behaviors for each device within an organization. This unique software architecture enables real-time processing of large data volumes, allowing for closed-loop security. By generating tailored security policies for various device classes, Ordr integrates these measures with existing multi-vendor network and security infrastructures, helping organizations effectively manage and protect their business-critical devices and systems.

IntelyCare

Series B in 2020
IntelyCare offers a digital workforce augmentation platform that combines a gig-model application with advanced data science to optimize staff resources and close the widening gap between workforce supply and demand. IntelyCare is revolutionizing the antiquated healthcare staffing market, filling nursing shifts at three times the industry average and giving post-acute facilities the tools to predict and manage staffing needs. The company’s engaging mobile app empowers nursing professionals with access to flexible, on-demand work opportunities, reducing burnout and attrition while increasing productivity.

Vesta Healthcare

Series A in 2020
Vesta Healthcare is an industry-leading technology and clinical services organization, dedicated to connecting caregiver insights to the rest of the care team. Vesta Healthcare proactively identifies the need for additional resources in the home and provides 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to create value-based population health programs that emphasize clinical quality, improved health outcomes and personalized engagement. Vesta Healthcare is headquartered in New York, NY.

Ginger

Series C in 2019
Ginger.io, Inc. operates a behavioral analytics platform that transforms mobile data into health insights, specifically focusing on mental healthcare. The platform provides users with instant access to evidence-based behavioral health coaching, therapy, and psychiatry through a smartphone application. This on-demand service connects behavioral health coaches, therapists, and psychiatrists to deliver personalized care around the clock. Users can collect and analyze both passive mobile sensor data and active patient-reported outcomes, allowing for the identification of behavioral patterns and novel findings. Ginger serves a diverse clientele, including researchers, physicians, healthcare providers, and millions of individuals through partnerships with leading employers and health plans. Founded in 2010 and headquartered in San Francisco, California, Ginger is dedicated to enhancing mental health support.

Protenus

Series C in 2019
The Protenus healthcare compliance analytics platform uses artificial intelligence to audit every access to patient records for the nation’s leading health systems. Providing healthcare leaders full insight into how health data is being used, and alerting compliance teams to policy violations, Protenus helps our partner hospitals make decisions about how to better protect their data, their patients, and their institutions. Learn more at Protenus.com and follow us on Twitter @Protenus.

Polarity

Series A in 2019
Polarity is a computer software company focused on enhancing collaboration and decision-making within organizations. It has developed a memory augmentation platform that analyzes the content displayed on users' computer screens, providing real-time access to relevant information without disrupting their current workflows. This technology not only streamlines internal communications but also integrates data from external sources, allowing teams to make informed and timely decisions through on-screen overlays. Polarity's innovative approach addresses common challenges in teamwork and information management, ultimately improving overall productivity.

Freenome

Series B in 2019
Freenome, Inc., is an artificial intelligence (AI) genomics biotech company. The company develops and provides a medical arti?cial intelligence platform for early detection of cancer. It develops blood tests for early-cancer screening and treatment selection. The company also provides clinical research services. Freenome, Inc. was founded in 2014 and is based in South San Francisco, California.

Nuvolo

Series B in 2019
Nuvolo Technologies Corporation offers a cloud-based enterprise asset management platform built on the ServiceNow framework. Established in 2013 and headquartered in Paramus, New Jersey, with additional offices in London, Bulgaria, and India, Nuvolo specializes in life-cycle management solutions for assets in clinics, laboratories, facilities, and manufacturing sectors. The company provides a comprehensive suite of services that includes implementation, support, tracking, reporting, and analytics, aimed at enhancing the user experience for mobile and remote workforces. Known for its commitment to innovation and customer service, Nuvolo has formed strategic partnerships with major firms such as Atos, KPMG, and Unisys to further its mission of becoming a leader in cloud-based enterprise asset management.

Omada Health

Series D in 2019
Omada Health, Inc. is a digital healthcare company that develops online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, the company collaborates with employers and health plans to identify individuals at risk for preventable chronic conditions such as prediabetes, diabetes, hypertension, and heart disease. Omada's programs are personalized to address the evolving needs of participants, offering support in areas like diabetes prevention, type 2 diabetes management, and behavioral health. The company integrates professional health coaching, connected health devices, real-time data, and personalized feedback to achieve clinically significant outcomes. Omada Health is recognized as the largest provider of the National Diabetes Prevention Program by the Centers for Disease Control and Prevention (CDC).

Health Catalyst

Series F in 2019
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.

Health Catalyst

Debt Financing in 2019
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.

Vesta Healthcare

Series A in 2018
Vesta Healthcare is an industry-leading technology and clinical services organization, dedicated to connecting caregiver insights to the rest of the care team. Vesta Healthcare proactively identifies the need for additional resources in the home and provides 24/7 telehealth support for caregivers and care recipients, with a focus on high-need, frail senior populations. Vesta partners with home care agencies, health plans and providers to create value-based population health programs that emphasize clinical quality, improved health outcomes and personalized engagement. Vesta Healthcare is headquartered in New York, NY.

Multisensor Diagnostics

Seed Round in 2018
Multisensor Diagnostics (MDx), LLC, is a diversified health and wellness company primarily serving the high-acuity patients.

CareAcademy

Seed Round in 2018
CareAcademy operates an online training platform tailored for senior home care agencies and caregivers. Founded in 2013 by Helen Adeosun, the company provides evidence-based classes that help direct care workers enhance their skills and improve the quality of care they deliver to older adults. The platform offers a variety of courses covering essential topics such as infection control, nutrition, dementia care, and fall prevention, enabling caregivers to meet licensure requirements across all 50 states. CareAcademy has certified over 40,000 caregivers nationwide, emphasizing the importance of high-touch coaching and exceptional customer service. The training programs not only equip caregivers with the necessary knowledge and skills but also offer peace of mind to employers, ensuring that their teams are well-prepared to support seniors in living independently and safely at home.

Protenus

Series B in 2018
The Protenus healthcare compliance analytics platform uses artificial intelligence to audit every access to patient records for the nation’s leading health systems. Providing healthcare leaders full insight into how health data is being used, and alerting compliance teams to policy violations, Protenus helps our partner hospitals make decisions about how to better protect their data, their patients, and their institutions. Learn more at Protenus.com and follow us on Twitter @Protenus.

Genome Medical

Series A in 2018
Genome Medical, Inc. is a national telegenomics company that specializes in providing genetic consultation and medical consulting services. Incorporated in 2016 and based in South San Francisco, California, the company utilizes its Genome Care Delivery technology platform to deliver genetic solutions across various clinical areas, including cancer, cardiovascular health, reproductive health, pediatrics, and pharmacy. By leveraging a nationwide network of genetic specialists, Genome Medical offers expert virtual genetic care to individuals and families, enhancing their health and well-being. The company also assists healthcare providers and patients in navigating the expanding field of genetics, enabling them to interpret test results, assess disease risk, expedite diagnoses, make informed treatment choices, and reduce healthcare costs.

Collective Medical

Series A in 2017
Collective Medical Technologies, Inc. is a health care technology company that specializes in a real-time collaboration software platform designed to enhance patient care. Founded in 2005 and based in Cottonwood Heights, Utah, the platform connects a patient's entire care team, including hospitals, primary and secondary clinics, health plans, and community organizations, facilitating the sharing of vital information. Collective Medical's system-agnostic platform is utilized by a nationwide network of health plans and providers to identify at-risk patients and encourage actionable collaboration among care teams. The platform aims to improve patient outcomes by reducing unnecessary emergency department visits and hospital readmissions, utilizing real-time data, risk analytics, and shared care guidelines to inform provider decision-making. As of December 30, 2020, Collective Medical operates as a subsidiary of PointClickCare Corp.

Protenus

Series A in 2017
The Protenus healthcare compliance analytics platform uses artificial intelligence to audit every access to patient records for the nation’s leading health systems. Providing healthcare leaders full insight into how health data is being used, and alerting compliance teams to policy violations, Protenus helps our partner hospitals make decisions about how to better protect their data, their patients, and their institutions. Learn more at Protenus.com and follow us on Twitter @Protenus.

Chrono Therapeutics

Series B in 2016
Chrono Therapeutics Inc., a digital transdermal drug delivery company, develops SmartStop, a digital nicotine replacement therapy. Its wearable solution tailors the timing and dose sizes of drugs, preempts predictable peak disease, and addiction symptoms with a device. The company was incorporated in 2003 and is based in Hayward, California.

Big Health

Series B in 2016
Big Health is a London-based company that develops and markets digital healthcare solutions focused on improving mental health and sleep disorders. Its flagship product, Sleepio, is a digital sleep improvement program that utilizes Cognitive Behavioral Therapy techniques to address individual sleep challenges. The platform offers fully-automated, personalized therapeutic sessions, allowing users to engage with their specific issues and track their progress. In addition to Sleepio, Big Health provides a broader digital healthcare portal that delivers customized behavioral programs aimed at various mental health concerns, all designed in consultation with medical professionals to ensure efficacy and relevance.

Torax Medical

Series E in 2016
Torax Medical, Inc. develops and markets products/devices to restore the barrier function of sphincters. The company’s products include LINX, a reflux management system to treat patients diagnosed with gastroesophageal reflux disease; and FENIX, a continence restoration system for the treatment of fecal incontinence. It sells its products in Europe and the United States. Torax Medical, Inc. was founded in 2002 and is based in Shoreview, Minnesota. As of March 23, 2017, Torax Medical, Inc. operates as a subsidiary of Ethicon, Inc.

Bluesight

Series C in 2016
Bluesight is a software tool developed by Kit Check, Inc. that focuses on substance tracking and drug diversion detection within hospital pharmacies. This platform is part of a broader suite of cloud-based solutions designed to enhance the efficiency of pharmacy operations, including medication tracking and kit automation. Kit Check, Inc. utilizes Internet of Things (IoT) technology to significantly reduce kit replenishment time while increasing accuracy and minimizing errors. The company serves hospitals and pharmacies throughout the United States and Canada, tracking a substantial volume of medication, which contributes to improved supply chain management and operational safety. Founded in 2011 and based in Washington, D.C., Kit Check continues to innovate in the healthcare technology sector.

CareGuardian

Series B in 2016
CareGuardian, founded in 2014, is dedicated to enhancing the visibility, recognition, and empowerment of caregivers, both professional and family. The company aims to deliver exceptional care and support for older adults by reimagining caregiver training and fostering connections among caregivers. CareGuardian recognizes the critical role that family caregivers play in ensuring the safety and well-being of older adults, and it extends its support to them as well. The organization operates in various regions, focusing on creating a network that promotes quality care and meaningful interactions for those involved in caregiving.

Vidyo

Series E in 2015
We’re video-enabling the world. Recognized in the Gartner Magic Quadrant as a leader and a visionary, Vidyo is used by organizations like Google, CERN, Etsy, Philips, Alibaba, Kaiser, DISA and others. We are tackling a huge challenge: to ensure that the world can take advantage of the endless benefits of video chat by making it better than any other form of communication, whether you are in the office - or far out in the field under challenging bandwidth and wifi conditions. Vidyo makes it easy to embed the most beautiful, resilient and immersive multiparty video chat into any application, on any connected device. In healthcare, banking, IoT, customer engagement, enterprise collaboration, government, field services and more, video chat is revolutionizing - while simplifying - how we communicate. We envision a future in which hospitals, banks, universities, police stations, data centers, manufacturing facilities and all places in between see elegant video chat as the sustainable and intuitive way for humans to better connect with one another - making us more productive while saving tons of time and resources. From Silicon Valley to New York, Europe, Asia-Pacific and beyond, Vidyo is one of the most diverse teams in tech, with hundreds of gifted employees living and sharing their experiences all over the world. We are beyond excited about what we’re building, and believe our mission is just getting started.

Group Health Cooperative

Acquisition in 2015
Group Health Cooperative is a member-governed, non-profit healthcare organization that coordinates care and coverage. The organization offers health plans for individuals and families; state and federal employees; and employers such as small and large groups including employer-sponsored group plans. It also provides various specialty care services at its medical centers in contracted hospitals; and healthcare, pharmacy, and drug formulary services. In addition, Group Health Cooperative conducts non-proprietary public-interest research on preventing, diagnosing, and treating major health problems in the areas of aging and geriatrics, health services and economics, alternative approaches to healing, healthy communities, behavior change, medication use and patient safety, biostatistics, mental health, cancer, obesity, cardiovascular health, preventive medicine, child and adolescent health, vaccines and infectious diseases, chronic illness management, women’s health, and health informatics. Group Health Cooperative was founded in January 1947 and is based in Seattle, Washington with administrative offices in Tukwila, Bellingham, Spokane, Tacoma, and Kennewick, Washington.

Vapotherm

Series C in 2015
Vapotherm, Inc. is a medical technology company based in Exeter, New Hampshire, specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat respiratory distress in patients of all ages. The company offers a range of Precision Flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocity through small-bore nasal interfaces. Additionally, Vapotherm provides various companion products such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for compressed air supply, and specialized adaptors and cannulas to enhance treatment delivery. The company also produces disposable patient circuits for aerosol nebulization and Oxygen Assist Modules to help maintain target oxygen levels. Vapotherm primarily sells its products to hospitals in the United States and through distributors in select international markets. Founded in 1993, Vapotherm aims to improve clinical outcomes and enhance the quality of life for patients.

Vapotherm

Series C in 2015
Vapotherm, Inc. is a medical technology company based in Exeter, New Hampshire, specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat respiratory distress in patients of all ages. The company offers a range of Precision Flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocity through small-bore nasal interfaces. Additionally, Vapotherm provides various companion products such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for compressed air supply, and specialized adaptors and cannulas to enhance treatment delivery. The company also produces disposable patient circuits for aerosol nebulization and Oxygen Assist Modules to help maintain target oxygen levels. Vapotherm primarily sells its products to hospitals in the United States and through distributors in select international markets. Founded in 1993, Vapotherm aims to improve clinical outcomes and enhance the quality of life for patients.

Validic

Series B in 2015
Validic, Inc. is a healthcare technology company that specializes in a cloud-based platform designed to collect and manage mobile health data from various Internet-enabled applications and devices. Founded in 2010 and headquartered in Durham, North Carolina, Validic provides solutions such as Validic Solution, which connects patient-recorded data from digital health applications and wearables to healthcare providers; Validic Connect, which offers access to less common clinical and consumer devices; and Validic Mobile, focused on data collection from digital health apps and in-home devices. The platform simplifies the management of personal health data, enabling wellness companies, healthcare providers, pharmaceuticals, and health plans to access and utilize this information effectively.

Health Catalyst

Series D in 2015
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.

Bluesight

Series B in 2015
Bluesight is a software tool developed by Kit Check, Inc. that focuses on substance tracking and drug diversion detection within hospital pharmacies. This platform is part of a broader suite of cloud-based solutions designed to enhance the efficiency of pharmacy operations, including medication tracking and kit automation. Kit Check, Inc. utilizes Internet of Things (IoT) technology to significantly reduce kit replenishment time while increasing accuracy and minimizing errors. The company serves hospitals and pharmacies throughout the United States and Canada, tracking a substantial volume of medication, which contributes to improved supply chain management and operational safety. Founded in 2011 and based in Washington, D.C., Kit Check continues to innovate in the healthcare technology sector.

Ginger

Series B in 2014
Ginger.io, Inc. operates a behavioral analytics platform that transforms mobile data into health insights, specifically focusing on mental healthcare. The platform provides users with instant access to evidence-based behavioral health coaching, therapy, and psychiatry through a smartphone application. This on-demand service connects behavioral health coaches, therapists, and psychiatrists to deliver personalized care around the clock. Users can collect and analyze both passive mobile sensor data and active patient-reported outcomes, allowing for the identification of behavioral patterns and novel findings. Ginger serves a diverse clientele, including researchers, physicians, healthcare providers, and millions of individuals through partnerships with leading employers and health plans. Founded in 2010 and headquartered in San Francisco, California, Ginger is dedicated to enhancing mental health support.

MetricStream

Venture Round in 2014
MetricStream, Inc. is a provider of governance, risk, and compliance software solutions, offering both cloud-based and on-premise applications. The company's product portfolio includes tools for audit management, regulatory compliance, quality management, and risk management, serving various industries such as pharmaceuticals, healthcare, financial services, and manufacturing. MetricStream's Enterprise Compliance Platform is designed to help organizations manage compliance with quality standards and industry regulations effectively. The company also offers specialized solutions for food safety, environmental health, and safety management, as well as healthcare accreditation and third-party risk management. In addition to its software offerings, MetricStream provides implementation, training, and customer support services to enhance user experience and ensure optimal utilization of its solutions. Founded in 1999 and headquartered in Palo Alto, California, MetricStream has established a strategic alliance with Tech Mahindra Limited and maintains a global presence with offices in multiple countries.

Valeritas

Series D in 2014
On June 30, 2020, Valeritas Holdings, Inc. went out of business as per its Chapter 11 liquidation filing under bankruptcy. Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.

Omada Health

Series B in 2014
Omada Health, Inc. is a digital healthcare company that develops online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, with an additional office in Atlanta, the company collaborates with employers and health plans to identify individuals at risk for preventable chronic conditions such as prediabetes, diabetes, hypertension, and heart disease. Omada's programs are personalized to address the evolving needs of participants, offering support in areas like diabetes prevention, type 2 diabetes management, and behavioral health. The company integrates professional health coaching, connected health devices, real-time data, and personalized feedback to achieve clinically significant outcomes. Omada Health is recognized as the largest provider of the National Diabetes Prevention Program by the Centers for Disease Control and Prevention (CDC).

Vapotherm

Series B in 2014
Vapotherm, Inc. is a medical technology company based in Exeter, New Hampshire, specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat respiratory distress in patients of all ages. The company offers a range of Precision Flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocity through small-bore nasal interfaces. Additionally, Vapotherm provides various companion products such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for compressed air supply, and specialized adaptors and cannulas to enhance treatment delivery. The company also produces disposable patient circuits for aerosol nebulization and Oxygen Assist Modules to help maintain target oxygen levels. Vapotherm primarily sells its products to hospitals in the United States and through distributors in select international markets. Founded in 1993, Vapotherm aims to improve clinical outcomes and enhance the quality of life for patients.

Transcend Medical

Series C in 2014
Transcend Medical, Inc., an ophthalmic device company, engages in the development of medical devices for the treatment of glaucoma. The company offers CyPass Micro-Stent, a micro-invasive tent that is inserted in the eye during routine cataract surgery; Vold Gonio Lens for use in micro-invasive glaucoma surgery. It also provides clinical trial services. Transcend Medical, Inc. was formerly known as iART Newco I, Inc. The company was founded in 2005 and is based in Menlo Park, California. As of March 23, 2016, Transcend Medical, Inc. operates as a subsidiary of Alcon Holdings, Inc.

Health Catalyst

Series C in 2014
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.

TriVascular

Series E in 2013
TriVascular is a medical device company focused on developing and commercializing technologies for the minimally invasive treatment of abdominal aortic aneurysms (AAA) and thoracic aorta conditions. Founded in 1998 and headquartered in Santa Rosa, California, the company offers a range of products, including the Ovation System, which features self-expanding stent grafts designed for endovascular aortic repair. This system incorporates polymer-filled sealing rings to enhance the effectiveness of the treatment. TriVascular markets its products through direct sales teams in the United States and several European countries, as well as through distributors in other regions. The company's innovations aim to address unmet clinical needs and promote improved patient outcomes by reducing the risks and costs associated with open surgical repairs.

Xanitos

Venture Round in 2013
Xanitos, Inc. is a contracted environmental services provider specializing in hospital housekeeping, patient transportation, and central laundry services across the United States. Founded in 2008 and based in Newtown Square, Pennsylvania, the company is known for its unique XRO system for cleaning patient rooms. Xanitos offers comprehensive linen and laundry management services, including the development of linen usage policies, assessments of linen utilization, and evaluations of laundry agreements. The company aims to enhance cleaning quality, improve patient satisfaction scores, and reduce hospital-acquired infections while also lowering turnaround times and operational costs. With a focus on delivering high-quality service, Xanitos has built a reputation for its exceptional operations management and commitment to client needs. Graeme Crothall, the founder and CEO, brings 40 years of experience in the industry, having successfully led multiple companies that collectively generate significant revenues.

Movable

Seed Round in 2013
Movable offers a wrist-worn activity monitor that measures all movement. Its product MOVband is a simple and fun wrist-worn activity monitor that measures all movement, not just steps. The company’s primary targets are corporate and school-based wellness programs.

Vapotherm

Series A in 2013
Vapotherm, Inc. is a medical technology company based in Exeter, New Hampshire, specializing in the development and commercialization of proprietary Hi-VNI technology products designed to treat respiratory distress in patients of all ages. The company offers a range of Precision Flow systems, including Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox, which deliver heated, humidified, and oxygenated air at high velocity through small-bore nasal interfaces. Additionally, Vapotherm provides various companion products such as the Vapotherm Transfer Unit for patient mobility, the Q50 compressor for compressed air supply, and specialized adaptors and cannulas to enhance treatment delivery. The company also produces disposable patient circuits for aerosol nebulization and Oxygen Assist Modules to help maintain target oxygen levels. Vapotherm primarily sells its products to hospitals in the United States and through distributors in select international markets. Founded in 1993, Vapotherm aims to improve clinical outcomes and enhance the quality of life for patients.

iRhythm Technologies

Series D in 2013
iRhythm Technologies, Inc. is a digital healthcare company focused on improving the diagnosis and monitoring of cardiac arrhythmias in patients. Headquartered in San Francisco, the company provides innovative ambulatory electrocardiogram (ECG) monitoring solutions, primarily through its flagship product, the Zio service. This service utilizes a lightweight, wire-free, patch-based biosensor that patients can wear for up to 14 days, allowing for continuous heart monitoring. The Zio system integrates cloud-based data analytics and machine-learning capabilities to transform extensive heartbeat data into actionable clinical insights. By streamlining the diagnostic process, iRhythm aims to enhance patient health outcomes and reduce unnecessary healthcare expenses. Additionally, the company collaborates with Verily Life Sciences to develop advanced atrial fibrillation screening and monitoring products. Established in 2006, iRhythm continues to lead in the digital healthcare space by redefining cardiac arrhythmia diagnosis.

AtheroMed

Private Equity Round in 2013
AtheroMed, Inc. develops treatments for peripheral arterial disease. The company was incorporated in 2006 and is headquartered in Menlo Park, California.

Health Catalyst

Series B in 2013
Health Catalyst is a company that specializes in data and analytics technology for healthcare organizations, addressing the challenges posed by the transition from paper to electronic health records. It focuses on organizing, normalizing, and linking disparate health data from various systems, making it easily searchable for all users, including those without technical expertise. Health Catalyst operates through two primary segments: the Technology segment, which is the main revenue driver, offers cloud-based data platforms, analytics applications, and support services, primarily through subscription and licensing agreements. The Professional Services segment provides a combination of analytics, implementation, strategic advisory, and outsourcing services, helping healthcare organizations effectively utilize the technology to improve outcomes and operational efficiency.

Nordic

Funding Round in 2013
Based in Madison, Wis., Nordic is the largest Epic consulting practice in the world and the industry leader in providing electronic health record (EHR) consulting services to healthcare organizations using Epic software. Nordic is the only firm to be ranked No. 1 by KLAS in Epic Implementation Support and Staffing since the report’s inception in 2012. In the most recent Best in KLAS Report, Nordic was named the KLAS Category Leader for the “Other Implementation” category, which includes services and methodology in revenue cycle, integration, lab and reporting. Founded in 2010, Nordic has worked with more than 125 clients in 40 states, partnering with more than a third of Epic’s clients.

Torax Medical

Series D in 2012
Torax Medical, Inc. develops and markets products/devices to restore the barrier function of sphincters. The company’s products include LINX, a reflux management system to treat patients diagnosed with gastroesophageal reflux disease; and FENIX, a continence restoration system for the treatment of fecal incontinence. It sells its products in Europe and the United States. Torax Medical, Inc. was founded in 2002 and is based in Shoreview, Minnesota. As of March 23, 2017, Torax Medical, Inc. operates as a subsidiary of Ethicon, Inc.

Agile Therapeutics

Series C in 2012
Agile Therapeutics, Inc., a specialty pharmaceutical company, engages in the development of women's healthcare products. It offers a low estrogen dose seven-day transdermal contraceptive patch system that delivers a combination of levonorgestrel and Ethinylestradiol. The company was founded in 1997 as Levotech, Inc. and changed its name to Agile Therapeutics, Inc. in April 2001. It is based in Princeton, New Jersey.

Oxford Immunotec

Venture Round in 2012
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on its innovative, patented T cell measurement technology. The company's first product is a TB test that diagnoses latent TB infection ( LTBI ) and TB disease. T-SPOT®.TB is an interferon gamma release assay ( IGRA ) which are designed to replace the century old Mantoux skin test ( TST ).

Astute Medical

Series C in 2012
Astute Medical, Inc. is a life science tools company focused on enhancing the diagnosis of high-risk medical conditions through the discovery and development of protein biomarkers for novel diagnostic tests. Established in 2007 and based in San Diego, California, with an additional location in Paris, the company specializes in prognostic biomarker validation, addressing rapid diagnosis and risk assessment for acute conditions such as abdominal pain, acute coronary syndromes, cerebrovascular injury, kidney injury, and sepsis. Its flagship product, NephroCheck, is a single-use cartridge designed to detect biomarkers of acute kidney injury, while the Astute140 meter converts the fluorescent signals from the NephroCheck test into a numerical result. Astute Medical operates in both the United States and Europe and is a subsidiary of bioMérieux S.A.

TriVascular

Series D in 2012
TriVascular is a medical device company focused on developing and commercializing technologies for the minimally invasive treatment of abdominal aortic aneurysms (AAA) and thoracic aorta conditions. Founded in 1998 and headquartered in Santa Rosa, California, the company offers a range of products, including the Ovation System, which features self-expanding stent grafts designed for endovascular aortic repair. This system incorporates polymer-filled sealing rings to enhance the effectiveness of the treatment. TriVascular markets its products through direct sales teams in the United States and several European countries, as well as through distributors in other regions. The company's innovations aim to address unmet clinical needs and promote improved patient outcomes by reducing the risks and costs associated with open surgical repairs.

GluMetrics

Venture Round in 2012
GluMetrics, Inc., a medical device company, develops tools that enable clinicians to implement a care paradigm for critically ill patients. Its products include GluCath, an intravascular continuous glucose monitoring system to measure blood sugar. The company was founded in 2005 and is based in Irvine, California.

AtheroMed

Series D in 2012
AtheroMed, Inc. develops treatments for peripheral arterial disease. The company was incorporated in 2006 and is headquartered in Menlo Park, California.

Transcend Medical

Series B in 2012
Transcend Medical, Inc., an ophthalmic device company, engages in the development of medical devices for the treatment of glaucoma. The company offers CyPass Micro-Stent, a micro-invasive tent that is inserted in the eye during routine cataract surgery; Vold Gonio Lens for use in micro-invasive glaucoma surgery. It also provides clinical trial services. Transcend Medical, Inc. was formerly known as iART Newco I, Inc. The company was founded in 2005 and is based in Menlo Park, California. As of March 23, 2016, Transcend Medical, Inc. operates as a subsidiary of Alcon Holdings, Inc.

CytoPherx

Series C in 2012
CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.

iRhythm Technologies

Private Equity Round in 2012
iRhythm Technologies, Inc. is a digital healthcare company focused on improving the diagnosis and monitoring of cardiac arrhythmias in patients. Headquartered in San Francisco, the company provides innovative ambulatory electrocardiogram (ECG) monitoring solutions, primarily through its flagship product, the Zio service. This service utilizes a lightweight, wire-free, patch-based biosensor that patients can wear for up to 14 days, allowing for continuous heart monitoring. The Zio system integrates cloud-based data analytics and machine-learning capabilities to transform extensive heartbeat data into actionable clinical insights. By streamlining the diagnostic process, iRhythm aims to enhance patient health outcomes and reduce unnecessary healthcare expenses. Additionally, the company collaborates with Verily Life Sciences to develop advanced atrial fibrillation screening and monitoring products. Established in 2006, iRhythm continues to lead in the digital healthcare space by redefining cardiac arrhythmia diagnosis.

Xanitos

Venture Round in 2011
Xanitos, Inc. is a contracted environmental services provider specializing in hospital housekeeping, patient transportation, and central laundry services across the United States. Founded in 2008 and based in Newtown Square, Pennsylvania, the company is known for its unique XRO system for cleaning patient rooms. Xanitos offers comprehensive linen and laundry management services, including the development of linen usage policies, assessments of linen utilization, and evaluations of laundry agreements. The company aims to enhance cleaning quality, improve patient satisfaction scores, and reduce hospital-acquired infections while also lowering turnaround times and operational costs. With a focus on delivering high-quality service, Xanitos has built a reputation for its exceptional operations management and commitment to client needs. Graeme Crothall, the founder and CEO, brings 40 years of experience in the industry, having successfully led multiple companies that collectively generate significant revenues.

Valeritas

Series C in 2011
On June 30, 2020, Valeritas Holdings, Inc. went out of business as per its Chapter 11 liquidation filing under bankruptcy. Valeritas Holdings, Inc., a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States. The company offers V-Go, a wearable insulin delivery device for basal-bolus therapy. It also develops V-Go Prefill that is in the design-development stage for eliminating the device-filling process and the need for EZ fill refrigeration for patients with Type 2 diabetes; and V-Go SIM for real-time tracking information of basal and bolus dosing utilization. The company sells V-Go to third-party wholesalers and medical supply distributors. Valeritas Holdings, Inc. was founded in 2006 and is headquartered in Bridgewater, New Jersey.

Transcend Medical

Series B in 2011
Transcend Medical, Inc., an ophthalmic device company, engages in the development of medical devices for the treatment of glaucoma. The company offers CyPass Micro-Stent, a micro-invasive tent that is inserted in the eye during routine cataract surgery; Vold Gonio Lens for use in micro-invasive glaucoma surgery. It also provides clinical trial services. Transcend Medical, Inc. was formerly known as iART Newco I, Inc. The company was founded in 2005 and is based in Menlo Park, California. As of March 23, 2016, Transcend Medical, Inc. operates as a subsidiary of Alcon Holdings, Inc.

Accumetrics

Venture Round in 2010
Accumetrics is a privately-held company based in San Diego, California, specializing in the development, manufacturing, and marketing of the VerifyNow System. This system comprises a comprehensive suite of assays designed for the assessment of platelet function, which is crucial in various medical applications, particularly in cardiovascular care. Founded in 1996, Accumetrics was initially sold to Radiometer in 2000 but was repurchased by its management and investors in 2003. The company continues to focus on providing essential tools for healthcare professionals to improve patient outcomes through effective monitoring of platelet activity.

Baxano

Series C in 2010
Baxano, Inc. develops minimally invasive tools to restore spine function and preserve healthy tissue. The company offers iO-Flex System, which targets and decompresses bone and soft tissue in the foramen, lateral recess, and central canal for patients with single and multi-level mild, moderate, and severe stenosis. Its products comprise Neuro Check device that allows the surgeon to confirm that the device is against the bone and the nerve is safely out of the way; MicroBlade ShaverTM instrument, which is used to remove the impinging bone and ligament; Guidewire; probes; and distal handles. The company was founded in 2005 and is based in San Jose, California.

Predictive Biosciences

Series C in 2010
Predictive Biosciences, Inc., a molecular diagnostics company, develops diagnostic products for informed cancer management. It specializes in proteomics, diagnostics, oncology, and tumor biomarkers. The company offers biomarkers and proteomics-based assay technologies. These assays detect urinary biomarkers associated with the physiological changes resulting from cancer development and progression. It also provides Triage Monitoring Assay, which allows physicians to delay and invasive diagnostic procedures; Interval Monitoring Assay that is for surveillance and detection of cancer between follow-ups; and Stratification Assay, which supports a physician's decision to manage a patient. Predictive Biosciences, Inc. was founded in 2006 and is headquartered in Lexington, Massachusetts.

Agile Therapeutics

Series B in 2010
Agile Therapeutics, Inc., a specialty pharmaceutical company, engages in the development of women's healthcare products. It offers a low estrogen dose seven-day transdermal contraceptive patch system that delivers a combination of levonorgestrel and Ethinylestradiol. The company was founded in 1997 as Levotech, Inc. and changed its name to Agile Therapeutics, Inc. in April 2001. It is based in Princeton, New Jersey.